e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Sarcoidosis: genes and mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2010 Abstract: Functional variant of the
ANXA11
gene: True marker of protection and candidate disease modifier in sarcoidosis
A. Stahelova, F. Mrazek, E. Kriegova, B. Hutyrova, Z. Kubistova, V. Kolek, M. Petrek (Olomouc, Czech Republic)
Source:
Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Session:
Sarcoidosis: genes and mechanisms
Session type:
Oral Presentation
Number:
3429
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Stahelova, F. Mrazek, E. Kriegova, B. Hutyrova, Z. Kubistova, V. Kolek, M. Petrek (Olomouc, Czech Republic). LSC 2010 Abstract: Functional variant of the
ANXA11
gene: True marker of protection and candidate disease modifier in sarcoidosis. Eur Respir J 2010; 36: Suppl. 54, 3429
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Related content which might interest you:
LSC 2010 Abstract: Influence of mutations and COPD clinical features on
SERPINA1
phenotypic expression
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Are there differences in the functional polymorphism of
FCGR3A
gene between sarcoidosis and tuberculosis?: Preliminary study
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
Disease modifier genes in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=50
Year: 2006
LSC 2010 Abstract: Possible effect of
GSTM1
and
GSTT1
polymorphisms on the risk for development of COPD and total antioxidant plasma capacity
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
Determination of a single nucleotide polymorphism (SNP) of the TNFalpha-R1 region (TNFRSF1A) in patients with lung sarcoidosis: Preliminary results
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
"Loss of function" variants of the
P2RX7
gene in Czech patients with sarcoidosis: A genetic association study
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010
Identification and characterisation of seven novel SERPINA1 null mutations
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014
Investigating tensin1 expression and the presence of SNP identified in GWAS in COPD
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Late Breaking Abstract: A genome-wide association study identifies variants at 12q13.3-q14.1 as genetic risk factors for sarcoidosis
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010
SNPs in SPINK5 gene region are associated with asthma severity: Preliminary results from the gene environment interactions in respiratory diseases (GEIRD) study
Source: Annual Congress 2013 –Genetic factors in airway development and disease
Year: 2013
The asthma-COPD overlap syndrome: Transcription factors GATA3 and STAT6 as possible markers
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Identification and distribution of rare and new mutations of Alpha-1-antitrypsin in Germany
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014
Polymorphism and copy number variation of FCGR genes in an etiopathogenesis of sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
Late Breaking Abstract - Functional investigation of the corticosteroid resistance candidate FKBP5 using a CRISPR-Cas9 knockout model
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017
LSC 2010 Abstract: Perforin expression in COPD patients with microsatellite DNA instability
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Gene expression profiling: can we identify the right target genes?
Source: Eur Respir Rev 2008; 17: 163-167
Year: 2008
The SNPs (-1654C/T, -1641A/G and -1476A/T) of protein C promoter are associated with susceptibility to pulmonary thromboembolism in a chinese population
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014
-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Single nucleotide polymorphism and asthma: A study on the genetic basis of asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
Asthma-COPD overlap syndrome (ACOS) versus ²pure² COPD: A distinct phenotype?
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept